News
-
-
-
-
-
PRESS RELEASE
Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth
Zomedica Corp. reports record revenue growth in Q1 2025, driven by strong performance of PulseVet® and TRUFORMA® products. International sales up 32% -
-
-
-
-